Once reconstituted with sterile diluent, refrigerate the solution and use within two weeks
It analyzes pathway-level variants (GIPR, FTO, and MC4R) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction
Frequently Asked Questions About Therapeutic Peptides in Orthopedics BPC-157 (Body Protection Compound-157) is a synthetic pentadecapeptide originally derived from a protein found in human gastric juice
Its gaining attention in biohacking, anti-aging, and performance optimization communities as a research chemical, often sold in 10mg capsules or vials for oral or injectable use
The peptide stimulates expression of early growth response 1 (EGR-1) gene, which regulates cytokine and growth factor generation along with early extracellular matrix formation, while simultaneously inducing its repressor NAB2 to prevent excessive angiogenic signaling
Administration Methods BPC-157 is commonly administered via subcutaneous injection